IIa trials

Related by string. IIa trial * IIAS . IIA : Phase IIa clinical trials . IIa clinical trial . Phase IIa . Phase IIa Clinical Trial . initiate Phase IIa / trialed . trialing . Trials . TRIAL . Trial : Phase III clinical trials . Week Premium Trial . Phase III trials . placebo controlled clinical trials . randomized controlled trial * Phase IIa trial . Phase IIa trials . Phase IIa Trial *

Related by context. Frequent words. (Click for all words.) 68 phase IIa 67 IIa trial 65 Phase Ib clinical 65 Phase IIB 64 Phase Ia 64 Phase 1a 64 phase IIa clinical 63 Phase 1b trial 63 phase IIb 63 pharmacokinetic PK 62 Mipomersen 62 INCB# [001] 62 Factor VIIa 62 phase 2a 62 TOLAMBA 62 Phase IIIb 61 Azedra 61 IPLEX 61 Phase 1b 61 placebo controlled clinical 61 Phase IIb trials 61 Phase Ib 61 Phase 2b clinical trials 61 DDP# 61 Phase IIa trial 61 Laquinimod 61 phase IIb clinical 61 forodesine 61 Phase 1b clinical 61 IMC #B 61 BZL# 61 liposomal formulation 60 Pivotal Phase III 60 Phase 2a clinical 60 pharmacodynamic effects 60 Phase III 60 ATL# [001] 60 IND submission 60 Phase 2a trial 60 enzastaurin 60 registrational 60 EndoTAG TM -1 60 SAR# [004] 60 Urocidin 60 dose escalation trial 60 confirmatory Phase III 60 Dasatinib 60 Phase II 59 anticancer compound 59 multiple ascending dose 59 teduglutide 59 AeroLEF TM 59 deforolimus 59 pharmacokinetics PK 59 Pivotal Trial 59 Traficet EN 59 orally bioavailable 59 EVIZON 59 APTIVUS 59 Phase 2b study 59 DP b# 59 elotuzumab 59 Phase III Clinical Trial 59 Sym# 59 Phase 2b trial 59 double blinded placebo 59 Phase 2a 59 MNTX 59 Thrombin 59 multicenter Phase 59 Phase IIb clinical 59 BLA submission 59 Diamyd ® 59 Phase IIa clinical 58 Cloretazine R VNP#M 58 STX# 58 bicifadine 58 Diamyd R 58 single ascending dose 58 interferon beta 1b 58 ZD# [001] 58 BrachySil 58 Virulizin R 58 BNC# 58 pertuzumab 58 Atu# 58 CCX# 58 axitinib 58 PEG SN# 58 GHRH 58 Phase IIa 58 HuMax CD# 58 proteasome inhibitor 58 radiolabeled 58 PA# [002] 58 RRMS patients 58 registrational trial 58 KRN# 58 VIAject 57 multicenter clinical 57 EFAPROXYN

Back to home page